Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation

ClinicalTrials.gov ID: NCT02554903

Public ClinicalTrials.gov record NCT02554903. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 10:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

STUDY OBJECTIVES Primary objective To evaluate the effect of macitentan 10 mg on pulmonary vascular resistance (PVR) as compared to placebo in subjects with pulmonary hypertension (PH) after left ventricular assist device (LVAD) implantation. Secondary objectives To evaluate the effect of macitentan 10 mg as compared to placebo on cardio-pulmonary hemodynamics and disease severity in subjects with PH after LVAD implantation. To evaluate the safety and tolerability of macitentan 10 mg in subjects with PH after LVAD implantation. Exploratory objectives To explore the potential effect of macitentan 10 mg as compared to placebo on right ventricular function in subjects with PH after LVAD implantation. To explore the potential effect of macitentan 10 mg as compared to placebo on selected clinical events in subjects with PH after LVAD implantation. To explore the potential effect of macitentan 10 mg as compared to placebo on renal function as measured by glomerular filtration rate (GFR) in subjects with PH after LVAD implantation.

Study identification

NCT ID
NCT02554903
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Actelion
Industry
Enrollment
57 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 27, 2016
Primary completion
Mar 12, 2020
Completion
Mar 12, 2020
Last update posted
Mar 29, 2025

2016 – 2020

United States locations

U.S. sites
50
U.S. states
25
U.S. cities
45
Facility City State ZIP Site status
#125_Mayo Clinic Arizona Phoenix Arizona 85054
#144_University of Arizona Tucson Arizona 85724
#106_Cedars-Sinai Medical Center Beverly Hills California 90211
#154_University of California San Diego La Jolla California 92037
#110_Sutter Heart Institute Sacramento California 95819
#132_University of California San Francisco San Francisco California 94143
#123_MedStar Washington Hospital Center Washington D.C. District of Columbia 20010
#126_Florida Hospital Orlando Florida 32804
#135_University of Chicago Medical Center Chicago Illinois 60637
#113_Advocate Christ Medical Center Oak Lawn Illinois 60453
#108_Indiana University Health Physicians Cardiology Indianapolis Indiana 46202
#112_St. Vincent Medical Group, Inc Indianapolis Indiana 46260
#120_University of Iowa Hospitals and Clinics Iowa City Iowa 52242
#117_University of Louisville Louisville Kentucky 40202
#105_Ochsner Medical Center New Orleans Louisiana 70121
#129_John Hopkins University Medical Center Baltimore Maryland 21287
#143_Tufts Medical Center Boston Massachusetts 02111
#138_Massachusetts General Hospital Boston Massachusetts 02114
#119_Brigham and Women's Hospital Boston Massachusetts 02115
#115_Henry Ford Hospital Detroit Michigan 48202
#102_Mayo Clinic Rochester Minnesota 55905
#150_Saint Luke's Hospital Kansas City Missouri 64111
#104_Washington University School of Medicine St Louis Missouri 63110
#131_University of Nebraska Medical Center Omaha Nebraska 68918
#103_Weill Cornell Medical College New York New York 10021
#139_Icahn School of Medicine at Mount Sinai New York New York 94080
#133_Montefiore Medical Center The Bronx New York 10467
#147_Westchester Medical Center Valhalla New York 10595
#148_University of Cincinnati Medical Center Cincinnati Ohio 45242
#153_Cleveland Clinic Cleveland Ohio 44195
#101_The Ohio State University Wexner Medical Center Columbus Ohio 43210
#145_The University of Toledo Medical Center Toledo Ohio 43614
#121_Integris Baptist Medical Center Oklahoma City Oklahoma 73112
#142_Penn State Heart and Vascular Institute Hershey Pennsylvania 17033
#140_Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
#134_Allegheny General Hospital Pittsburgh Pennsylvania 15212
#130_University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Medical University of South Carolina Charleston South Carolina 29425
#141_Palmetto Health / Palmetto Heart Columbia South Carolina 29203
#151_Stern Cardiovascular Foundation Memphis Tennessee 38120
#146_Vanderbilt University Medical Center Nashville Tennessee 37232
#149_Seton Heart Institute Austin Texas 78705
#136_Baylor Health - Baylor University Medical Center Dallas Texas 75226
#107_Houston Methodist Hospital Houston Texas 77030
#122_Advanced Heart Failure Clinic - HCM San Antonio Texas 78229
#127_The University of Utah Salt Lake City Utah 84112
#114_University of Virginia Charlottesville Virginia 22905
#111_Inova Fairfax Hospital Falls Church Virginia 22042
#116_Virginia Commonwealth University (VCU) Medical Center Richmond Virginia 23298
#155_University of Wisconsin Hospital and Clinics Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02554903, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 29, 2025 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02554903 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →